Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04362579
Other study ID # STU00210698
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2021
Est. completion date December 1, 2021

Study information

Verified date March 2022
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring


Description:

The primary objective of the Prentice study is to assess and validate EMG performance of the new home-use sensor with extended battery life in detecting continuous EHG in a range of uterine contraction intensities, frequencies, and durations compared to gold-standard FDA-cleared tocodynamometer (GE Corometrics 250cx) in non-stress testing for antepartum surveillance. An "at-home" study will validate the developed modifications to the wearable sensors system that provides a continuous electrohysterography (EHG) along with other additional physiological parameters (e.g. heart rate, heart rate variability, sleep quality, physical activity, and continuous blood pressure) for longitudinal monitoring in the home setting.


Recruitment information / eligibility

Status Completed
Enrollment 91
Est. completion date December 1, 2021
Est. primary completion date December 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility - Maternal age >18 years old - Pregnant mothers >13 weeks (home study only) - Pregnant mothers >26 weeks undergoing nonstress testing or delivering - Singleton pregnancy (inpatient or clinic visit patients only) - History of preterm labor or premature birth, active smoker, chronic condition (ex: HTN or DM), or an interval of less than 6 months between the prior pregnancy - Singleton pregnancy (home study only) - No fetal abnormality or chromosomal abnormality - Subjects willing and able to comply with requirements of the protocol Exclusion Criteria - Women who refuse to signed the informed consent form - Maternal age under 18 years old - Multiple pregnancy - Known major fetal malformation or chromosomal abnormality - Medical or obstetric problem that would preclude the use of abdominal electrodes - Inability to consent to this study due to medical illness, diminished intellectual capacity, or language barrier - Women using pacemakers

Study Design


Related Conditions & MeSH terms


Intervention

Device:
wearable vital signs sensor
vital signs monitoring during maternal non-stress testing or in the home setting

Locations

Country Name City State
United States Northwestern University Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Device comparison to standard monitoring The primary outcome measure is concordance of FHR tracing assessments from Rogers sensor recordings with those obtained from the current standard of care electronic fetal monitoring systems. 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT05520021 - The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat N/A
Recruiting NCT04154423 - Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study N/A
Completed NCT03785795 - Multichannel EMG Diagnosing True Preterm Labor
Recruiting NCT06110143 - Oral Health and Adverse Pregnancy Complications N/A
Completed NCT05430633 - Laparoscopic Versus Open Appendectomy in Pregnancy
Completed NCT03956810 - Evaluation of the Prenatal Trip Assistance Pilot Project N/A
Recruiting NCT05651347 - Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction Phase 3
Recruiting NCT04332393 - Metformin to Treat Corticosteroids-induced Hyperglycemia Phase 4
Completed NCT04074525 - Evaluating Decisional Regret Among Mothers
Completed NCT02707237 - Maternal Counseling for Preterm Deliveries, Assessing an Effective Method of Counseling N/A
Recruiting NCT02166645 - Comparison Between Preterm Infants Who Are Placed on Their Back or Stomach in the Immediate Postextubation Period N/A
Completed NCT03076775 - Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study N/A
Recruiting NCT05264779 - The Periviable GOALS Decision Support Tool N/A
Not yet recruiting NCT05412056 - Metformin to Prevent Preterm Birth in Twin Pregnancy Phase 2/Phase 3
Active, not recruiting NCT04433364 - COPE - COVID-19 in Pregnancy and Early Childhood
Completed NCT04989673 - Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French Guiana
Recruiting NCT05345457 - Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age Phase 4
Completed NCT03429257 - Maternal EED and Aflatoxin Birth Outcomes Study Uganda N/A
Withdrawn NCT03738293 - Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids
Completed NCT03675061 - Evaluation of Vaginal PAMG-1 Detection by PartoSure Test in Preterm Delivery Threat in Actual Clinical Situation: Randomized Controlled Trial N/A